oxotremorine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadjiconstantinou, M | 1 |
| Hubble, JP | 1 |
| Wemlinger, TA | 1 |
| Neff, NH | 1 |
1 other study available for oxotremorine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Carbachol; Corpus Striatum; Dopamine; Drug S | 1994 |